XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.22.1

Net Income (Loss) Per Share | 3 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share [Abstract] |
Net Income (Loss) Per Share | NET INCOME (LOSS) PER SHAREThe following table sets forth the computation of net income (loss) per common share:
| Three Months Ended March 31,
| 2022 |  | 2021
Net (loss) income per share |  |  |
Numerator |  |  |
Net (loss) income | $ | (5,558) |  |  | $ | 8,090 |
Denominator |  |  |
Denominator for basic net (loss) income per weighted average common shares | 97,873,452 |  |  | 31,558,754 |
Effect of dilutive securities |  |  |
Warrants | — |  |  | 5,186,007 |
Private warrants | — |  |  | 4,988,719 |
Stock options | — |  |  | 10,589,093 |
Denominator for diluted net (loss) income per weighted average common shares | 97,873,452 |  |  | 52,322,573 |
Net (loss) income per common share |  |  |
Basic | $ | (0.06) |  |  | $ | 0.26 |
Diluted | $ | (0.06) |  |  | $ | 0.15 |
The Company’s potentially dilutive securities, which include unvested RSUs, stock options to purchase common stock and warrants to purchase common stock, have been excluded from the computation of diluted net income (loss) per share for certain periods, as the effect would be antidilutive. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net (loss) income per share is the same in periods of a net loss. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net (loss) income per share for the periods indicated because including them would have had an anti-dilutive effect:
| Three Months Ended March 31,
| 2022 |  | 2021
Public warrants | 12,500,000 |  |  | — |
Private warrants | 332,500 |  |  | — |
Stock options | 8,442,265 |  |  | — |
Unvested restricted stock units | 6,274,361 |  |  | 19,000,000 |
Total common stock equivalents | 27,549,126 |  |  | 19,000,000 |
Unvested restricted stock units that were outstanding during the three months ended March 31, 2021 were not included in the computation of diluted EPS because the performance obligation related to these restricted stock units had not occurred as of the reporting date.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration